V souladu s legislativou České republiky poskytuje Společnost služby pouze kvalifikovaným investorům!

Akoya Biosciences (AKYA) Financial results for the third quarter of 2021.

09.11.2021

GAAP net loss is -$0.31.

Revenue is $13,48 million that is 35,5% higher than the same period last year